bromodeoxyuridine has been researched along with fenretinide in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Akai, H; Andoh, N; Denda, A; Horiguchi, K; Kobayashi, Y; Konishi, Y; Nakae, D; Satoh, H; Tamura, K; Tsujiuchi, T; Yoshiji, H | 1 |
2 other study(ies) available for bromodeoxyuridine and fenretinide
| Article | Year |
|---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Inhibition by N-(4-hydroxyphenyl)retinamide and all-trans-retinoic acid of exogenous and endogenous development of putative preneoplastic, glutathione S-transferase placental form-positive lesions in the livers of rats.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Animals; Anticarcinogenic Agents; Bromodeoxyuridine; Choline Deficiency; Deoxyguanosine; Fenretinide; Glutathione Transferase; Liver; Liver Neoplasms, Experimental; Male; Placenta; Precancerous Conditions; Rats; Rats, Inbred F344; Tretinoin | 1997 |